FL
Fort LP Portfolio holdings
AUM
$39.6M
This Quarter Return
-17.11%
1 Year Return
+37.11%
3 Year Return
+56.81%
5 Year Return
+128.27%
10 Year Return
+343.53%
AUM
$446M
AUM Growth
+$446M
(-21%)
Cap. Flow
-$9.81M
Cap. Flow
% of AUM
-2.2%
Top 10 Holdings %
Top 10 Hldgs %
6.86%
Holding
475
New
30
Increased
141
Reduced
192
Closed
112
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$587K |
| 2 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
$574K |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
$551K |
| 4 |
CERN
Cerner Corp
CERN
|
$534K |
| 5 |
Adobe
ADBE
|
$532K |
Top Sells
| 1 |
Global Payments
GPN
|
$1.31M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$634K |
| 3 |
Walt Disney
DIS
|
$552K |
| 4 |
Cable One
CABO
|
$544K |
| 5 |
MZTI
The Marzetti Company Common Stock
MZTI
|
$504K |
Sector Composition
| 1 | Technology | 24.29% |
| 2 | Industrials | 23% |
| 3 | Healthcare | 16.77% |
| 4 | Consumer Staples | 13.49% |
| 5 | Consumer Discretionary | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTXS
1
DELISTED
Citrix Systems Inc
CTXS
| $3.68M | 0.83% | 26,017 -377 | -1% | -$53.4K |
|
|
2
Cable One
CABO
$909M
| $3.2M | 0.72% | 1,945 -331 | -15% | -$544K |
|
3
Eli Lilly
LLY
$657B
| $3.07M | 0.69% | 22,160 -874 | -4% | -$121K |
|
4
Gilead Sciences
GILD
$140B
| $3.06M | 0.69% | 40,987 +201 | +0.5% | +$15K |
|
5
Tyler Technologies
TYL
$24.4B
| $3M | 0.67% | 10,098 -808 | -7% | -$240K |
|
6
Clorox
CLX
$14.5B
| $2.98M | 0.67% | 17,198 -25 | -0.1% | -$4.33K |
|
7
Microsoft
MSFT
$3.77T
| $2.94M | 0.66% | 18,667 -1,319 | -7% | -$208K |
|
8
Hormel Foods
HRL
$14B
| $2.93M | 0.66% | 62,825 +220 | +0.4% | +$10.3K |
|
9
Apple
AAPL
$3.45T
| $2.9M | 0.65% | 11,388 -1,131 | -9% | -$288K |
|
10
Leidos
LDOS
$23.2B
| $2.85M | 0.64% | 31,050 -2,721 | -8% | -$249K |
|
11
WD-40
WDFC
$2.92B
| $2.85M | 0.64% | 14,170 -25 | -0.2% | -$5.02K |
|
|
ANSS
12
DELISTED
Ansys
ANSS
| $2.78M | 0.62% | 11,938 -869 | -7% | -$202K |
|
13
Jack Henry & Associates
JKHY
$11.9B
| $2.76M | 0.62% | 17,753 -360 | -2% | -$55.9K |
|
14
Chemed
CHE
$6.67B
| $2.74M | 0.61% | 6,314 -387 | -6% | -$168K |
|
15
Exponent
EXPO
$3.6B
| $2.72M | 0.61% | 37,781 -1,360 | -3% | -$97.8K |
|
16
Graco
GGG
$14.1B
| $2.71M | 0.61% | 55,600 -490 | -0.9% | -$23.9K |
|
17
Amgen
AMGN
$155B
| $2.69M | 0.6% | 13,244 -160 | -1% | -$32.4K |
|
18
Bristol-Myers Squibb
BMY
$96B
| $2.66M | 0.6% | 47,668 -4,937 | -9% | -$275K |
|
19
CoStar Group
CSGP
$37.9B
| $2.63M | 0.59% | 4,486 -393 | -8% | -$231K |
|
20
General Mills
GIS
$26.4B
| $2.63M | 0.59% | 49,907 -3,026 | -6% | -$160K |
|
21
Booz Allen Hamilton
BAH
$13.4B
| $2.62M | 0.59% | 38,210 -2,138 | -5% | -$147K |
|
22
Johnson & Johnson
JNJ
$427B
| $2.61M | 0.58% | 19,880 +42 | +0.2% | +$5.51K |
|
23
Danaher
DHR
$147B
| $2.6M | 0.58% | 18,813 -737 | -4% | -$102K |
|
24
UnitedHealth
UNH
$281B
| $2.59M | 0.58% | 10,403 -40 | -0.4% | -$9.97K |
|
25
AbbVie
ABBV
$372B
| $2.58M | 0.58% | 33,839 +2,069 | +7% | +$158K |
|